Article
Elevated plasma dihydroorotate in Miller syndrome: Biochemical, diagnostic and clinical implications, and treatment with uridine.
Molecular genetics and metabolism - 1 Sept 2016
Duley John A, Henman Michael G, Carpenter Kevin H, Bamshad Michael J, Marshall George A, Ooi Chee Y, Wilcken Bridget, Pinner Jason R
Abstract excerpt
BACKGROUND: Miller syndrome (post-axial acrofacial dysostosis) arises from gene mutations for the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH). Nonetheless, despite demonstrated loss of enzyme activity dihydroorotate (DHO) has not been shown to accumulate, but paradoxically urine orotate has been reported to be raised, confusing the metabolic diagnosis. METHODS: We analysed plasma and urine from a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
